In a regulatory filing, Rapport Therapeutics (RAPP) disclosed that its director Steven Paul bought 41.7K shares of common stock on September 12th in a total transaction size of $1.03M.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAPP: